{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:18:04Z","timestamp":1765808284532,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>As methadone can prevent the development of opioid resistance, it has application in alleviating cancer-related pain that proves challenging to manage with other opioids. QT interval prolongation is a serious side effect of methadone treatment, with some reported deaths. In particular, owing to the increased risk of QT interval prolongation, caution should be exercised when using it in combination with drugs that also prolong the QT interval.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>This study presents a case in which methadone was introduced to a patient (a man in his 60s) already using levofloxacin, which could prolong the QT interval\u2014a serious side effect of methadone treatment\u2014and whose QTc value tended to increase. Given that levofloxacin can increase the risk of QT interval prolongation, we considered switching to other antibacterial agents before introducing methadone. However, because the neurosurgeon judged that controlling a brain abscess was a priority, low-dose methadone was introduced with continuing levofloxacin. Owing to the risks, we performed frequent electrocardiograms. Consequently, we responded before the QTc increased enough to meet the diagnostic criteria for QT interval prolongation. Consequently, we prevented the occurrence of drug-induced long QT syndrome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>When considering the use of methadone for intractable cancer pain, it is important to eliminate possible risk factors for QT interval prolongation. However, as it may be difficult to discontinue concomitant drugs owing to comorbidities, there could be cases in which the risk of QT interval prolongation could increase, even with the introduction of low-dose methadone. In such cases, frequent monitoring, even with simple measurements such as those used in this case, is likely to prevent progression to more serious conditions.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40780-023-00322-w","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T14:02:47Z","timestamp":1704204167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A case with a trend of QT interval prolongation due to the introduction of methadone to a pancreatic cancer patient on levofloxacin"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5031-6394","authenticated-orcid":false,"given":"Ryusuke","family":"Ouchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Munenori","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinju","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mie","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"322_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0304-3940(97)13391-2","volume":"223","author":"LA Gorman","year":"1997","unstructured":"Gorman LA, Elliott KJ, Inturrisi CE. The d- and l-isomers of methadone bind to the non-competitive site on the N-methyl-D-aspartate (NMDA) receptor in rat forebrain and spinal cord. Neurosci Lett. 1997;223:5\u20138.","journal-title":"Neurosci Lett."},{"key":"322_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1046\/j.1365-2125.1997.t01-1-00591.x","volume":"44","author":"K Wolff","year":"1997","unstructured":"Wolff K, Rostami-Hodjegan A, Shires S, Hay AWM, Feely M, Calvert R, et al. The pharmacokinetics of methadone in healthy subjects and opiate users. Br J Clin Pharmacol. 1997;44:325\u201334.","journal-title":"Br J Clin Pharmacol."},{"key":"322_CR3","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1124\/jpet.102.038240","volume":"303","author":"AN Katchman","year":"2002","unstructured":"Katchman AN, McGroary KA, Kilborn MJ, Kornick CA, Manfredi PL, Woosley RL, et al. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J Pharmacol Exp Ther. 2002;303:688\u201364.","journal-title":"J Pharmacol Exp Ther."},{"key":"322_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0304-3959(03)00205-7","volume":"105","author":"CA Kornick","year":"2003","unstructured":"Kornick CA, Kilborn MJ, Santiago-Palma J, Schulman G, Thaler HT, Keefe DL, et al. QTc interval prolongation associated with intravenous methadone. Pain. 2003;105:499\u2013506.","journal-title":"Pain."},{"key":"322_CR5","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/pds.1276","volume":"15","author":"LJ Paulozzi","year":"2006","unstructured":"Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006;15:618\u201367.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"322_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1472-8206.2010.00871.x","volume":"25","author":"A Perrin-Terrin","year":"2011","unstructured":"Perrin-Terrin A, Pathak A, Lapeyre-Mestre M. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France. Fundam Clin Pharmacol. 2011;25:503\u201310.","journal-title":"Fundam Clin Pharmacol."},{"key":"322_CR7","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/psp4.12085","volume":"5","author":"L Kervezee","year":"2016","unstructured":"Kervezee L, Gotta V, Stevens J, Birkhoff W, Kamerling IMC, Danhof M, et al. Levofloxacin-induced QTc prolongation depends on the time of drug administration. CPT Pharmacometrics Syst Pharmacol. 2016;5:466\u201374.","journal-title":"CPT Pharmacometrics Syst Pharmacol."},{"key":"322_CR8","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00520-014-2171-x","volume":"22","author":"JP Turner","year":"2014","unstructured":"Turner JP, Shakib S, Singhal N, Hogan-Doran J, Prowse R, Johns S, et al. Prevalence and factors associated with polypharmacy in older people with cancer. Supp Care Cancer. 2014;22:1727\u201334.","journal-title":"Supp Care Cancer."},{"key":"322_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/jpm.2009.0184","volume":"13","author":"S Reddy","year":"2010","unstructured":"Reddy S, Hui D, El Osta B, de la Cruz M, Walker P, Palmer JL, et al. The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med. 2010;13:33\u20138.","journal-title":"J Palliat Med."},{"key":"322_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11606-009-1225-0","volume":"25","author":"V Modesto-Lowe","year":"2010","unstructured":"Modesto-Lowe V, Brooks D, Petry N. Methadone deaths: risk factors in pain and addicted populations. J Gen Intern Med. 2010;25:305\u20139.","journal-title":"J Gen Intern Med."},{"key":"322_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jpainsymman.2007.11.003","volume":"36","author":"RA Cruciani","year":"2008","unstructured":"Cruciani RA. Methadone: to ECG or not to ECG\u2026 that is still the question. J Pain Symptom Manag. 2008;36:545\u201352.","journal-title":"J Pain Symptom Manag."},{"key":"322_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/MAJ.0b013e318266e7af","volume":"345","author":"JC Winton","year":"2013","unstructured":"Winton JC, Twilla JD. Sudden cardiac arrest in a patient on chronic methadone after the addition of azithromycin. Am J Med Sci. 2013;345:160\u20132.","journal-title":"Am J Med Sci."},{"key":"322_CR13","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/0002-9149(87)90824-1","volume":"59","author":"JA Lopez","year":"1987","unstructured":"Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T. QT prolongation and torsades de pointes after administration of trimethoprim-sulfamethoxazole. Am J Cardiol. 1987;59:376\u20137.","journal-title":"Am J Cardiol."},{"key":"322_CR14","doi-asserted-by":"publisher","first-page":"10613","DOI":"10.1073\/pnas.180223197","volume":"97","author":"F Sesti","year":"2000","unstructured":"Sesti F, Abbott GW, Wei J, Murray KT, Saksena S, Schwartz PJ, et al. A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A. 2000;97:10613\u20138.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"322_CR15","doi-asserted-by":"publisher","first-page":"e41055","DOI":"10.2196\/41055","volume":"7","author":"N Yuan","year":"2023","unstructured":"Yuan N, Oesterle A, Botting P, Chugh S, Albert C, Ebinger J, et al. High-throughput assessment of real-world medication effects on QT interval prolongation: observational study. JMIR Cardio. 2023;7:e41055.","journal-title":"JMIR Cardio."},{"key":"322_CR16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/jgf2.485","volume":"23","author":"K Kubo","year":"2022","unstructured":"Kubo K, Sakakibara T, Yonezawa K, Kato M. Vonoprazan-associated long QT syndrome. J Gen Fam Med. 2022;23:54\u20135.","journal-title":"J Gen Fam Med."},{"key":"322_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/cts.12452","volume":"10","author":"B Astruc","year":"2017","unstructured":"Astruc B, Jenkins H, Jenkins R. Effect of therapeutic and Supratherapeutic doses of Vonoprazan on the QT\/QTc interval in a phase I randomized study in healthy subjects. Clin Transl Sci. 2017;10:208\u201316.","journal-title":"Clin Transl Sci."},{"key":"322_CR18","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1345\/aph.1H423","volume":"41","author":"JR Horn","year":"2007","unstructured":"Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41:674\u201380.","journal-title":"Ann Pharmacother."}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-023-00322-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-023-00322-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-023-00322-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T14:16:44Z","timestamp":1704205004000},"score":1,"resource":{"primary":{"URL":"https:\/\/jphcs.biomedcentral.com\/articles\/10.1186\/s40780-023-00322-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["322"],"URL":"https:\/\/doi.org\/10.1186\/s40780-023-00322-w","relation":{},"ISSN":["2055-0294"],"issn-type":[{"type":"electronic","value":"2055-0294"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient, and we complied with the guidelines on patient privacy protection (Surgery-related Academic Society Council) for medical papers, including case reports and presentations at academic meetings. We also obtained approval from the Institutional Review Board of Tohoku Medical and Pharmaceutical University Hospital (no. 2023\u20134-028).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}